PGC ANTI-MRSA

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePGC ANTI-MRSA
Drug Alias NamePGC-lysostaphinlysostaphin (PharmaIN)
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Enzyme
Mechanisms of ActionLysostaphin stimulants
TargetsLysostaphin
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmaIN Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaIN Corp
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A